Evidence map›Paper›PMID 27484907›Full record

ArticleMolecules and cells2016

Epigenetic and Glucocorticoid Receptor-Mediated Regulation of Glutathione Peroxidase 3 in Lung Cancer Cells.

Byung Chull An, Nak-Kyun Jung, Chun Young Park, In-Jae Oh, Yoo-Duk Choi, Jae-Il Park, Seung-Won Lee

Open access · diamondAbstract read
In one paragraph

Article in Molecules and cells, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 22 papers.

0numbers the graph read from it
0cells of the map it votes in
22citing papers in PubMed
3.9field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

22 citing papers in PubMed, 34 citations in OpenAlex.

  1. Review
  2. Review
  3. Article
  4. Review
  5. Article
  6. Article
  7. Review
  8. Review
  9. Article
  10. Article
  11. Prognostic value and immunological roles of GPX3 in gastric cancer.International journal of medical sciences · 2023
    Article
  12. Review
  13. Article
  14. Article
  15. Review
  16. Article
  17. Review
  18. Review
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 2 institutions in 1 country.

Byung Chull AnDepartment of Anatomy, Chonnam National University Medical School, Hwasun 58128, Korea.
Nak-Kyun JungDepartment of Anatomy, Chonnam National University Medical School, Hwasun 58128, Korea.
Chun Young ParkDepartment of Pathology, Chonnam National University Medical School, Hwasun 58128, Korea.
In-Jae OhDepartment of Internal Medicine, Chonnam National University Medical School, Hwasun 58128, Korea.
Yoo-Duk ChoiDepartment of Pathology, Chonnam National University Medical School, Hwasun 58128, Korea.
Jae-Il ParkAnimal Facility of Aging Science, Korea Basic Science Institute, Gwangju 61186, Korea.
Seung-Won LeeDepartment of Anatomy, Chonnam National University Medical School, Hwasun 58128, Korea.
Chonnam National University Hwasun Hospital · KRKorea Basic Science Institute · KR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Glutathione peroxidase 3 (GPx3), an antioxidant enzyme, acts as a modulator of redox signaling, has immunomodulatory function, and catalyzes the detoxification of reactive oxygen species (ROS). GPx3 has been identified as a tumor suppressor in many cancers. Although hyper-methylation of the GPx3 promoter has been shown to down-regulate its expression, other mechanisms by which GPx3 expression is regulated have not been reported. The aim of this study was to further elucidate the mechanisms of GPx3 regulation. GPx3 gene analysis predicted the presence of ten glucocorticoid response elements (GREs) on the GPx3 gene. This result prompted us to investigate whether GPx3 expression is regulated by the glucocorticoid receptor (GR), which is implicated in tumor response to chemotherapy. The corticosteroid dexamethasone (Dex) was used to examine the possible relationship between GR and GPx3 expression. Dex significantly induced GPx3 expression in H1299, H1650, and H1975 cell lines, which exhibit low levels of GPx3 expression under normal conditions. The results of EMSA and ChIP-PCR suggest that GR binds directly to GRE 6 and 7, both of which are located near the GPx3 promoter. Assessment of GPx3 transcription efficiency using a luciferase reporter system showed that blocking formation of the GR-GRE complexes reduced luciferase activity by 7-8-fold. Suppression of GR expression by siRNA transfection also induced down-regulation of GPx3. These data indicate that GPx3 expression can be regulated independently via epigenetic or GR-mediated mechanisms in lung cancer cells, and suggest that GPx3 could potentiate glucocorticoid (GC)-mediated anti-inflammatory signaling in lung cancer cells.

Indexed as

Antineoplastic AgentsCell Line, TumorDexamethasoneDNA MethylationEpigenesis, GeneticGene Expression Regulation, NeoplasticGlutathione PeroxidaseHumansLung NeoplasmsPromoter Regions, GeneticReceptors, GlucocorticoidResponse ElementsRNA, Small InterferingTumor Suppressor ProteinsAntineoplastic AgentsDexamethasoneGlutathione PeroxidaseGPX3 protein, humanReceptors, GlucocorticoidRNA, Small InterferingTumor Suppressor Proteinsdexamethasonegene regulationglucocorticoid receptorglucocorticoid response elementglucocorticoidsglutathione peroxidase-3

Identifiers

PMID27484907
PMCPMC4990756
OpenAlexW2510641924

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-SA
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.